Send the following on WhatsApp
Continue to ChatRuxolitinib, Jakafi* USA, avec l'indication myélofibrose. https://www.pharmacorama.com/2012/01/ruxolitinib-jakafi-usa-indication-myelofibrose/
Ruxolitinib, Jakafi* USA, avec l'indication myélofibrose. https://www.pharmacorama.com/2012/01/ruxolitinib-jakafi-usa-indication-myelofibrose/